Improved survival for children with B-cell acute lymphoblastic leukemia and stage IV small noncleaved-cell lymphoma: A Pediatric Oncology Group study

Keyphrases

• Acute Lymphoblastic Leukemia 100%
• B-cell Acute Lymphoblastic Leukemia (B-ALL) 100%
• Group Studies 100%
• Immunoglobulin 100%
• Pediatric Oncology 100%
• Improved Survival 100%
• Cell Lymphoma 100%
• Event-free Survival 33%
• Complete Remission 33%
• Survival Rate 33%
• Ara-C 33%
• B Cells 16%
• CNS Disorders 16%
• Working Diagnosis 16%
• Improved Outcomes 16%
• Cell Surface 16%
• Intrathecal Methotrexate 16%
• Treatment Plan 16%
• High-dose Methotrexate (HD-MTX) 16%
• Doxorubicin 16%
• Cyclophosphamide 16%
• Tumor Mass 16%
• Completion of Therapy 16%
• CNS Involvement 16%
• Plan-based 16%
• Abdominal Tumor 16%
• Intensified Chemotherapy 16%
• B-cell Malignancies 16%
• High-dose Cytarabine 16%

Medicine and Dentistry

• Acute Lymphoblastic Leukemia 100%
• Acute B-Cell Lymphoblastic Leukemia 100%
• Childhood Cancer 100%
• Undifferentiated Lymphoma 100%
• Lymphocyte Membrane Immunoglobulin 83%
• Cytarabine 50%
• Event Free Survival 33%
• B Cell 33%
• Methotrexate 33%
• Survival Rate 33%
• Drug Megadose 16%
• Vincristine 16%
• Cancer 16%
• Doxorubicin 16%
• Central Nervous System Disease 16%
• Cyclophosphamide 16%
• Abdominal Tumor 16%
• Cell Surface Immunoglobulin 16%
• Chemotherapy 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Acute Lymphoblastic Leukemia 100%
• Childhood Cancer 100%
• Undifferentiated Lymphoma 100%
• Lymphocyte Membrane Immunoglobulin 71%
• Cytarabine 42%
• Remission 28%
• Methotrexate 28%
• Event Free Survival 28%
• Survival Rate 28%
• Vincristine 14%
• Chemotherapy 14%
• Intrathecal 14%
• Doxorubicin 14%
• Cyclophosphamide 14%
• Central Nervous System Disease 14%
• Cell Surface Immunoglobulin 14%
• Abdominal Tumor 14%